Nephrogenic diabetes insipidus: genes and variants

Explore variant evidence for Nephrogenic diabetes insipidus across 2 analyzed proteins (AQP2, AVPR2). Linked ClinVar records include 26 pathogenic or likely pathogenic variants, 6 variants of uncertain significance and 2 with conflicting classifications.

Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Counts refer to the selected disease label.

Data updated 2026-11-05. Automated aggregation, not a clinical review date.

Download variant evidence (CSV)

Genes linked to Nephrogenic diabetes insipidus

ClinVar pathogenic and likely pathogenic variants linked to Nephrogenic diabetes insipidus

VariantPositionProtein partClinical label
AQP2 R187H187Discontinuously helicalPathogenic / likely pathogenic (★★)
AQP2 R187C187Discontinuously helicalPathogenic / likely pathogenic (★★)
AQP2 G64R64CytoplasmicPathogenic / likely pathogenic (★★)
AVPR2 R137H137CytoplasmicPathogenic / likely pathogenic (★★)
AQP2 A47V47TransmembranePathogenic / likely pathogenic (★★)
AVPR2 P322L322TransmembranePathogenic / likely pathogenic (★★)
AQP2 Q57P57TransmembranePathogenic / likely pathogenic (★★)
AQP2 G100V100TransmembranePathogenic / likely pathogenic (★★)
AQP2 A147T147TransmembranePathogenic / likely pathogenic (★★)
AQP2 V168M168TransmembranePathogenic / likely pathogenic (★★)
AVPR2 R104C104ExtracellularPathogenic / likely pathogenic (★★)
AVPR2 Y205C205TransmembranePathogenic / likely pathogenic (★★)
AQP2 T126M126ExtracellularPathogenic / likely pathogenic (★★)
AQP2 T125M125ExtracellularPathogenic / likely pathogenic (★★)
AQP2 P185A185Discontinuously helicalPathogenic / likely pathogenic (★★)
AQP2 P262L262CytoplasmicPathogenic / likely pathogenic (★★)
AVPR2 P322T322TransmembranePathogenic / likely pathogenic (★)
AQP2 G175R175TransmembranePathogenic / likely pathogenic (★)
AQP2 A190T190Discontinuously helicalPathogenic / likely pathogenic (★)
AQP2 S216P216TransmembranePathogenic / likely pathogenic (★)
AVPR2 L59P59TransmembranePathogenic / likely pathogenic (★)
AQP2 E258K258CytoplasmicPathogenic / likely pathogenic (★)
AVPR2 A285P285TransmembranePathogenic / likely pathogenic (★)
AQP2 M1I1CytoplasmicPathogenic / likely pathogenic (★)
AQP2 C75G75CytoplasmicPathogenic / likely pathogenic (★)
AQP2 R254Q254CytoplasmicPathogenic / likely pathogenic (★)

Which prediction tools work for Nephrogenic diabetes insipidus

Observed separation of ClinVar pathogenic / likely pathogenic from benign / likely benign variants (AUROC × 100). This benchmark is not a clinical recommendation.

Same protein, different disease

Diseases related to Nephrogenic diabetes insipidus

Frequently asked questions

Which genes have records linked to Nephrogenic diabetes insipidus?

This view contains 2 analyzed proteins: AQP2, AVPR2. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.

What do the clinical classifications mean?

Linked records include 26 pathogenic or likely pathogenic variants, 6 variants of uncertain significance and 2 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.

Does the evidence score change a VUS classification?

No. 0 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.

Can I download the variant evidence?

Download the CSV for all 104 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.

About this data

Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.

Download every variant as CSV · Browse all diseases · Methods · About the Center